Skip to main content
Wellcome Open Research logoLink to Wellcome Open Research
. 2024 Mar 14;8:551. Originally published 2023 Nov 28. [Version 2] doi: 10.12688/wellcomeopenres.20200.2

Mortality among non-severely under nourished children with pneumonia globally: protocol for a systematic review and meta-analysis

Damalie Nalwanga 1,2, Caitlin Bakker 3, Andrew Kiggwe 2, Abel Abera Negash 4,5, Moses Ocan 6, Andre Briend 7,8, Kathryn Maitland 9,10,a, Victor Musiiime 1,11,#, Charles Karamagi 1,12,#
PMCID: PMC10891427  PMID: 38404639

Version Changes

Revised. Amendments from Version 1

The new version includes 1) Replacement of the mention of nutritional outcomes to anthropometric outcomes 2) Slight revision to the secondary review questions 3) More details added to the statistical section 4) Addition of a conclusion 5) Change of reference 18.

Abstract

Background

Pneumonia remains the commonest cause of ill health and mortality among children worldwide. Severe undernutrition increases the mortality risk among children with pneumonia. While children with pneumonia are at increased risk of developing malnutrition, the impact of pneumonia on mortality and nutritional status of non-severely undernourished children is not well described. The impact of nutritional supplementation on mortality and nutritional status in this population is not well understood. This review will collate available evidence on the all-cause mortality and anthropometric indices outcomes following pneumonia, as well as the impact of nutritional supplementation on mortality and anthropometry among non-severely malnourished children with pneumonia.

Methods

The review will be done using a priori criteria developed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. Data will be obtained from data bases, grey literature, and bibliographies. An experienced librarian will conduct article search in PUBMED, MEDLINE, EMBASE, Web of Science, Google scholar, and Scopus. Retrieved articles will be entered in Endnote ver 9.0, duplicates removed, and transferred to Epi-reviewer for screening and data abstraction. Risk of bias in the included articles will be assessed using standard criteria. Heterogeneity will be assessed using I 2-statistic and sub-group analysis will be done. Data will be analysed using both narrative and quantitative synthesis. Quantitative synthesis will be done using DeSimonian and Laird Random-effects model in STATA ver 15.0.

Conclusions

The results will provide baseline information about the mortality and anthropometric outcomes of pneumonia among non-severely malnourished children as well as the potential effect of nutritional supplementation on these outcomes. This will provide a basis to explore the potential for nutritional supplementation improving clinical outcomes like mortality and occurrence of severe acute malnutrition among children with severe pneumonia worldwide.

Registration

The review has been registered in PROSPERO (CRD42021257272; 15 July 2021).

Keywords: Undernutrition, mortality, pneumonia, nutritional supplementation, children

Introduction

Worldwide, pneumonia remains the commonest cause of ill-heath and mortality among children under 5 years old 1, 2 . Overall, 14% of all under-5 mortalities and 22% of mortalities among children 1-5 years are attributed to pneumonia, and majority occur in low- and middle-income countries (LMICs) where undernutrition is also most prevalent 14 . Mortality from pneumonia has widely been associated with and attributed to childhood undernutrition 3, 5, 6 . The risk of severe pneumonia and mortality increases with the severity of undernutrition 79 . However, children with non-severe malnutrition and pneumonia are likely to progress to more severe forms of malnutrition, significantly increasing their risk of acquiring severe pneumonia and dying.

Undernutrition predisposes children to severe pneumonia via reduced immune responses towards infectious agents 7, 911 . Pneumonia causes a reduction in appetite, and often vomiting, as well as increase in energy demands required to support physiological changes like pyrexia and increased work of breathing 12, 13 . As a result, children with pneumonia have an increased risk of developing undernutrition. This vicious cycle of pneumonia and undernutrition 11, 14 significantly increases the children’s risk of death, especially as undernutrition becomes more severe 9, 15, 16 . Prevention of undernutrition through screening and timely intervention e.g., through macronutrient supplementation in at-risk populations, such as children with pneumonia, could break the vicious cycle and significantly reduce pneumonia mortality.

The current treatment guidelines provide for identification and nutritional rehabilitation of children with severe acute malnutrition. However, there is no recommendation for nutritional supplementation among non-severely malnourished children with acute infections like pneumonia despite their imminent risk of developing severe forms of malnutrition. The World Health Organization (WHO) and UNICEF recommend “continued feeding” in their Protect, Prevent, and Treat framework for pneumonia management. However, there is no specific guidance on how feeding could be modified for better outcomes in the sick child, or whether nutritional supplementation could be beneficial 17 . This could be due to scanty evidence supporting the need for nutritional support among non-severely malnourished children with pneumonia.

We propose a systematic review and meta-analysis to assess the all-cause mortality, as well as nutritional (anthropometry) outcomes of non-severely malnourished children with pneumonia, and to evaluate the impact of macronutrient supplement on mortality and anthropometry. This review will help to fill the information gap on the all-cause mortality among non-severely malnourished children with pneumonia, as well as compile available data on macronutrient supplement tested to reduce mortality and improve nutritional outcomes in this population. This information will provide evidence to utilize in developing guidelines or provide a basis for further studies to tackle the problem of pneumonia related mortality in this population.

Protocol

Study design

The review will be conducted following a priori criteria developed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA-P) guide 18 . The review title has been registered in PROSPERO ( CRD42021257272; 15 July 2021) 19 . The protocol has been reported according to the PRISMA-P guidelines 20 .

Research question

Primary review question

What is the all-cause mortality among non-severely malnourished children (2 months to 17 years old) with community acquired pneumonia globally?

Secondary review questions

  • What is the mean change in anthropometric outcomes i.e., mid-upper-arm-circumference (MUAC), Weight for Height z-score (WHZ), Weight for Age z-score (WAZ), BMI for age z score (BAZ) or Height for age z-score (HAZ) among non-severely malnourished children (2 months to 17 years) with pneumonia globally?

  • What is the mean change in anthropometric status i.e., MUAC, WHZ, WAZ, BMI for age z score (BAZ) and HAT among non-severely malnourished children (2 months to 17 years old) with community acquired pneumonia who received a macronutrient supplement compared to those who did not receive globally?

  • What is the all-cause mortality among non-severely malnourished children (2 months to 17 years old) with community acquired pneumonia who received a macronutrient supplement compared to those who did not receive globally?

Eligibility criteria

Inclusion criteria

  • Articles published from 2000 to-date in peer-reviewed journals. This is because the WHO manual, which developed uniform ways for monitoring nutrition and diagnosis of malnutrition, was made in 1999 21 .

  • Articles that report on mortality, and change in anthropometric status such as MUAC, WHZ, WAZ, or HAZ among non-severely malnourished children with pneumonia.

  • Articles that report macronutrient supplementation such as ready to use therapeutic foods (RUTF) or enriched food given for any duration.

Exclusion criteria

  • Articles from studies done exclusively among severely malnourished children, neonates (children under 1 month old) or older than 18 years old, and among children with hospital acquired pneumonia.

Data sources

The data sources will include databases (PUBMED, Medical Literature Analysis and Retrieval System Online (MEDLINE), EMBASE, Web of Science, Cochrane Central, Google scholar, and Scopus), grey literature/bibliography, institutional websites and libraries, as well as published authors/ experts in the area.

Data items

In this review, data will be sought on the following: community acquired pneumonia (CAP) among children ≥1 month ≤18 years old (population), non-severe malnutrition (exposure), mortality, change in anthropometric status (outcome), design of studies used to establish the all-cause mortality among non-severely malnourished children with pneumonia (study design), source of funding of the studies, and year when the studies were done (time period).

Search strategy

The search for studies will be conducted systematically in databases including PUBMED, Medical Literature Analysis and Retrieval System Online (MEDLINE), EMBASE, Web of Science, Cochrane Central, Google scholar, and Scopus. The article search will be carried out by one re searcher (AK), and independently checked by another CB. The search terms will be combined using Boolean operators “AND” and “OR” for additive and restrictive combination of search terms as necessary. Websites of institutions that handle the population of interest will also be checked. The preliminary search in the PUBMED database is indicated in Table 1. The search string will be developed based on the population, intervention/exposure, Comparator, outcome (PICO), as summarised in Table 2. We shall also review the bibliographies of selected articles and contact lead researchers in the field for any additional potentially relevant article (s) from their research.

Table 1. Preliminary Search Strategy for PUBMED.

PUBMED
1 Diet Therapy
2 Nutrition Therapy
3 undernourish* OR malnourish* OR poorly nourish* OR malnutrition
4 diet* OR diet therap* OR nutrition* OR nutrition* therap* OR nutrition* intervention* OR Nutrition* treatment* OR nutrition*
status OR nutrition* modification OR nutrition*supplement*
5 macronutrient* OR calorie# OR caloric OR carbohydrate*intake OR protein* intake OR fat intake OR fat diet OR fats intake OR fats
diet)
6 (diet OR food) AND nutrition
7 nutrition disorder* OR child nutrition disorder* OR infant nutrition disorder* OR malnutrition
8 "ready to use therapeutic food" OR "ready to use therapeutic food" OR "ready-to-use therapeutic food" OR "ready-to-use therapeutic
food" OR RTUF OR food* supplement*
9 Dietary Carbohydrates OR Dietary Proteins OR Fats OR Fortified
10 Dietary supplements OR functional food
11 or/1-10
12 pneumonia
13 pneumonias OR pneumonic
14 12 or 13
15 Neonates OR premature infants OR infant OR newborn OR infant OR infant behavior OR child, preschool OR child behavior OR child
development OR child psychiatry OR orthopsychiatry OR child psychology OR child behavior disorders OR pediatrics OR child OR
puberty OR adolescent OR adolescent behavior OR adolescent development OR adolescent psychiatry OR adolescent psychology
OR young adult OR schools, nursery OR child day care centers OR child care OR education, graduate OR universities OR students
OR schools
16 preterm OR premature OR postmature OR perinatal OR postnatal OR neonatal OR newborn OR new-born OR infant OR baby
OR babies OR toddler* OR preschool* OR child* OR pediatric OR paediatric OR kid OR kids OR prepubescent OR prepuberty OR
puberty OR pubescen* OR teen* OR young* OR youth* OR minors OR under age OR underage OR juvenile* OR girl* OR boy* OR
preadolesc* OR adolesc*
17 15 or 16
18 11 and 14 and 17
19 Mortality OR survival OR death
20 18 and 19
21 limit 20 to yr="2000 -Current" (what I sent later)-less study design filters
22 Exclude animals
23 Limit to Clinical Trials, multicentre trials, RCTs, pragmatic clinical trials and pragmatic clinical studies

Table 2. PICOS definitions.

Population     •   Children ≥1 month ≤ 18 years
    •   Community acquired Pneumonia (World Health Organization (WHO) definition), lower respiratory tract infection, respiratory tract infection
    •   Globally
    •   Hospitals (any level of health facility)
    •   Sample size
    •   Age <1 month/ neonate, or adults/> 18 years
    •   Hospital acquired pneumonia
    •   Pneumonia among specific categories of patients e.g., intensive care unit (ICU) patients, cystic fibrosis, post-operative patients, sickle cell patients
    •   Pneumonia diagnosed only by chest X-ray or culture and sensitivity, C-reactive protein (CRP) only
Exposure/Intervention for interventional studies     •   Malnutrition or anthropometric status, underweight, undernourished, stunted
    •   Any nutritional intervention; with food e.g., porridge, rice porridge, or other enriched food, ready to use therapeutic food (RUTF)
    •   Reports only on severely malnourished
children
    •   Micronutrient-only interventions e.g., zinc, iron, selenium, Vitamins etc.
Outcome     •   Mortality/death
    •   Any change in mid upper arm circumference (MUAC), weight for height z scores (WHZ), body mass index (BMI), skinfold thickness, bio-impedance analysis (BIA)
    •   Any outcomes other than mortality and change in MUAC
Study Design     •   Observational/ Cohort
    •   Cross-sectional
    •   Randomized controlled trial (RCT)
    •   Survey
    •   Interventional but non-randomized
    •   Systematic Review
    •   Case report
    •   Case series
Time Period     •   Published after 1999 (2000 and beyond)

Article screening

Three pairs of independent reviewers (DN, LN, TK, GK, RA and MO) will screen the articles using pre-determined screening criteria, first using titles and abstracts, and then using the selected full texts. The selection of studies will be performed independently in pairs that will be blinded to each other’s decisions. After unblinding, the two reviewers will resolve any conflicts by consensus. A third reviewer will analyse and decide in cases where there are conflicting decisions but no consensus.

Data extraction

The tool for data abstraction will be developed in Excel spreadsheet and will include sections on: general study information including the country research was done and year of data collection and publication; the study design, study population and comparators if any; anthropometric status and its assessment method, and intervention used if any; mortality proportions and anthropometric status outcome. The tool will be piloted in six 6 articles and the findings used to adjust the tool. The tool will then be used to develop an abstraction screen in Epi-Reviewer software. Data abstraction will be done by (DN, LN, TK, GK, RA and MO). The reviewers will be paired and any disagreements between any pair resolved through discussion and consensus. Further disagreement will be referred to a tie breaker. Authors will be contacted in cases where more information, or clarification is required.

Quality assessment

Assessment of the quality of studies included will be done to evaluate bias and reliability of the evidence using standardized tools (The Risk of Bias in Non-randomised Studies - of Interventions (ROBINS-I) for non-randomized interventional studies, Cochrane risk-of-bias tool revised for randomized trials and the Risk of Bias in Non-randomised Studies (ROBINS) for observational studies). Two reviewers will independently carry out the validity assessment. Any disagreement between the reviewers will be resolved by discussion and consensus.

Data management

The identified articles from the different databases will be imported into Endnote reference manager™ version X7 (Thomson Reuters, 2015). Articles will be screened for duplicates, which will be removed. The EPPI-Reviewer™ Software (UK) version 6 tool will be used for article screening (title and abstract), full text screening and data abstraction.

Heterogeneity assessment

We shall measure heterogeneity among studies using the I 2 statistic to estimate the percentage of variation among the studies included in the review. A heterogeneity will be considered low if the I 2 statistic ranges between 0% to 40%, moderate if it ranges between 30% to 60%, substantial if it ranges between 50% to 90%, and high if it is 75% to 100% 22, 23 .

Data analysis and synthesis

Data will be analysed using both narrative and quantitative synthesis methods. Categorical data from all the individual studies will be summarized as frequencies and percentages and numerical continuous data as means and standard deviations or median and interquartile range for parametric and non-parametric data, respectively. Quantitative synthesis will be done using DeSimonian and Laird Random-effects model in STATA ver 18.0. For the calculation of pooled effect estimates we will consider a confidence interval (CI) = 95% and α = 0.05 using EPPI-Reviewer™ Software (UK). The results will be presented in PRISMA 2020 flow chart 18 and as forest plots and sub- group analyses will be carried out by participant age, duration of follow up, severity of pneumonia as specified in the selected articles. From heterogeneity analysis, we shall identify the articles to be included in quantitative analysis. For intervention studies that qualify for quantitative synthesis, further assessment of how categorical study characteristics are associated with the intervention effects will be done (meta-regression). A p-value of 0.05 will be considered statistically significant for all hypothesis testing.

Publication bias assessment

Publication bias refers to how the research findings impact the chances that a study is published or not. We shall explore the probability of publication bias among the selected articles using funnel plots and assessing the symmetry of the plots. Adjustment for publication bias will be performed by the trim and fill method 24 .

Patient and public involvement

The study will include research articles and have no direct engagement of patients or members of the public.

Ethics and dissemination

As there will be no direct involvement of human subjects, ethics approval is not applicable. We shall disseminate the research finding to clinicians and researchers through dissemination meetings, conferences, and in peer-reviewed publications. No sex and/or gender (which are based on self-reporting within the manuscripts reviewed) differences are expected in the results.

Study status

The article search has been completed. Screening by title and abstract has also been completed. Screening by full text is ongoing.

Discussion

This study aims to assess the all-cause mortality, as well as anthropometric outcomes among non-severely malnourished children with pneumonia, and to evaluate the impact of macronutrient supplementation on mortality and anthropometry.

Results from this study will help to document the all-cause mortality among non-severely malnourished children with pneumonia, as well as their anthropometric outcomes following pneumonia episodes. We also hope to document the effect of nutritional supplementation on mortality and anthropometric outcomes in this population. This will provide some baseline evidence on the need for nutritional rehabilitation among non-severely malnourished children with pneumonia in order to potentially reduce pneumonia mortality and improve anthropometric outcomes in this population.

Strengths and limitations

Strengths

Restricting the review to the period when the WHO manual with uniform ways for monitoring nutrition and diagnosis of malnutrition in children was in effect will help generate comparable evidence on mortality among non-severely nourished children with pneumonia, and the effect of supplementary food on anthropometric outcomes in this population.

Including studies published globally will help in providing context to the findings of the review.

Limitations

The settings in which the primary studies were conducted, as well as the level of care given to the children may not be uniform, which could impact the findings from this study.

Conclusion

This review will collate available evidence on the all-cause mortality, anthropometric outcomes following pneumonia, as well as the impact of nutritional supplementation on mortality and anthropometry among non-severely malnourished children with pneumonia.

Acknowledgements

We acknowledge the support of members of the Africa Centre for Systematic reviews and evidence synthesis.

Funding Statement

The review is funded in part by the UK Joint Global Health Trials scheme: Medical Research Council, Department for International Development Wellcome Trust (MR/L004364/1) and by European and Developing Countries Clinical Trials Partnership (RIA2016S-1636) awarded to Professor Kathryn Maitland. Additional funding is provided by the government of Uganda through Makerere University Research and Innovations Fund (RIF1/CAES/030) awarded to Dr Damalie Nalwanga. It was also supported through KEMRI-Wellcome Trust Research Programme – Mbale Clinical Research Institute Core Support (203077, <a href=https://doi.org/10.35802/203077>https://doi.org/10.35802/203077</a>].

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[version 2; peer review: 3 approved]

Data availability

Underlying data

No data are associated with this article.

Reporting guidelines

The protocol has been reported according to the PRISMA-P guidelines.

Imperial College Research Data Repository: PRISMA checklist for ‘Mortality among non-severely under nourished children with pneumonia globally: protocol for a systematic review and meta-analysis’. https://doi.org/10.14469/hpc/13333 20 .

Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication).

References

  • 1. McAllister DA, Liu L, Shi T, et al. : Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. 2019;7(1):e47–e57. 10.1016/S2214-109X(18)30408-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. World Health Organisation: Pneumonia. WHO website,2022. Reference Source
  • 3. Sonego M, Pellegrin MC, Becker G, et al. : Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies. PLoS One. 2015;10(1): e0116380. 10.1371/journal.pone.0116380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. World Health Organization, United Nations Children's Fund (‎UNICEF)‎, World Bank Levels and trends in child malnutrition: UNICEF / WHO / The World Bank Group joint child malnutrition estimates: key findings of the 2021 edition.Geneva PP - Geneva: World Health Organization. Reference Source
  • 5. Ngari MM, Fegan G, Mwangome MK, et al. : Mortality after Inpatient Treatment for Severe Pneumonia in Children: a Cohort Study. Paediatr Perinat Epidemiol. 2017;31(3):233–242. 10.1111/ppe.12348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Moïsi JC, Gatakaa H, Berkley JA, et al. : Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. Bull World Health Organ. 2011;89(10):725–32, 732A. 10.2471/BLT.11.089235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Chisti MJ, Tebruegge M, La Vincente S, et al. : Pneumonia in severely malnourished children in developing countries-mortality risk, aetiology and validity of WHO clinical signs: a systematic review. Trop Med Int Health. 2009;14(10):1173–89. 10.1111/j.1365-3156.2009.02364.x [DOI] [PubMed] [Google Scholar]
  • 8. Chisti MJ, Salam MA, Bardhan PK, et al. : Treatment Failure and Mortality amongst Children with Severe Acute Malnutrition Presenting with Cough or Respiratory Difficulty and Radiological Pneumonia. PLoS One. 2015;10(10): e0140327. 10.1371/journal.pone.0140327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Kirolos A, Blacow RM, Parajuli A, et al. : The impact of childhood malnutrition on mortality from pneumonia: a systematic review and network meta-analysis. BMJ Glob Health. 2021;6(11): e007411. 10.1136/bmjgh-2021-007411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Jackson S, Mathews KH, Pulanić D, et al. : Risk factors for severe acute lower respiratory infections in children: a systematic review and meta-analysis. Croat Med J. 2013;54(2):110–21. 10.3325/cmj.2013.54.110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Walson JL, Berkley JA: The impact of malnutrition on childhood infections. Curr Opin Infect Dis. 2018;31(3):231–236. 10.1097/QCO.0000000000000448 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Quadros DRS, Kamenwa R, Akech S, et al. : Hospital-acquired malnutrition in children at a tertiary care hospital. South Afr J Clin Nutr. 2018;31(1):8–13. 10.1080/16070658.2017.1322825 [DOI] [Google Scholar]
  • 13. Rocha GA, Rocha EJM, Martins CV: The effects of hospitalization on the nutritional status of children. J Pediatr (Rio J). 2006;82(1):70–4. [DOI] [PubMed] [Google Scholar]
  • 14. Katona P, Katona-Apte J: The interaction between nutrition and infection. Clin Infect Dis. 2008;46(10):1582–8. 10.1086/587658 [DOI] [PubMed] [Google Scholar]
  • 15. Rahman AE, Hossain AT, Nair H, et al. : Prevalence of hypoxaemia in children with pneumonia in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Glob Health. 2022;10(3):e348–59. 10.1016/S2214-109X(21)00586-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Caulfield LE, de Onis M, Blössner M, et al. : Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr. 2004;80(1):193–8. 10.1093/ajcn/80.1.193 [DOI] [PubMed] [Google Scholar]
  • 17. Qazi S, Aboubaker S, MacLean R, et al. : Ending preventable child deaths from pneumonia and diarrhoea by 2025. Development of the integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea. Arch Dis Child. 2015;100 Suppl 1:S23–8. 10.1136/archdischild-2013-305429 [DOI] [PubMed] [Google Scholar]
  • 18. Moher D, Shamseer L, Clarke M, et al. : Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1): 1. 10.1186/2046-4053-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Morgan RL, Whaley P, Thayer KA, et al. : Identifying the PECO: a framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environ Int. 2018;121(Pt 1):1027–1031. 10.1016/j.envint.2018.07.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Maitland K: PRISMA Check List and Flow diagram for Mortality among non-severely under nourished children with pneumonia globally: protocol for a systematic review and meta-analysis.Imperial College Research Data Repository. [Dataset]. 10.14469/hpc/13333 [DOI] [PMC free article] [PubMed]
  • 21. World Health Organization: Management of severe malnutrition: a manual for physicians and other senior health workers.World Health Organization;1999. Reference Source
  • 22. Higgins JPT, Thompson SG, Deeks JJ, et al. : Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. 10.1136/bmj.327.7414.557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Higgins JPT, Thompson SG: Quantifying heterogeneity in a meta‐analysis. Stat Med. 2002;21(11):1539–58. 10.1002/sim.1186 [DOI] [PubMed] [Google Scholar]
  • 24. Duval S, Tweedie R: Trim and fill: a simple funnel‐plot-based method of testing and adjusting for publication bias in meta‐analysis. Biometrics. 2000;56(2):455–63. 10.1111/j.0006-341x.2000.00455.x [DOI] [PubMed] [Google Scholar]
Wellcome Open Res. 2024 Mar 28. doi: 10.21956/wellcomeopenres.23401.r76795

Reviewer response for version 2

Felix Bongomin 1

The authors have addressed  all comments sufficiently.

Is the study design appropriate for the research question?

Yes

Is the rationale for, and objectives of, the study clearly described?

Yes

Are sufficient details of the methods provided to allow replication by others?

Partly

Are the datasets clearly presented in a useable and accessible format?

Yes

Reviewer Expertise:

Internal Medicine, Medical Microbiology and Research Methodology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Wellcome Open Res. 2024 Feb 21. doi: 10.21956/wellcomeopenres.22363.r72532

Reviewer response for version 1

Olivier Marcy 1

This is an interesting, needed, and well written meta-analysis protocol on pneumonia and non-severe or moderate acute malnutrition (MAM) in children and adolescents, and particularly on the impact of MAM on pneumonia mortality and vice-versa of pneumonia on occurrence of severe acute malnutrition (SAM), as well as the effect of micronutrient on nutritional and vital outcomes. When there is a wealth of data on the impact of MAM/SAM on pneumonia mortality, impact of pneumonia on nutritional outcomes is much less documented. Micronutrient supplementation could play an important role in reducing severe outcomes and findings from this study could have important public health impact.

I have 3 comments to consider if possible either at protocol stage or in the analysis.

  1. 0 to 19 is quite a wide age range and MAM in children below the age of 5 years is quite different than in adolescents aged >10 as defined by the WHO or above 13-14. I would suggest stratifying the analysis by age group and having a strong focus on the age group 2 to 59 months, which bears the highest burden in terms of mortality.

  2. I agree with using several malnutrition indicators and suggest adding BMI for age between -2 and -3 SD as an indicator for MAM in children above the age of 5.

  3.  I suggest phrasing objective #2 as objective#3 is phrased and introducing the notion of comparison between groups rather than stating “due to macronutrient supplementation”.

Is the study design appropriate for the research question?

Yes

Is the rationale for, and objectives of, the study clearly described?

Yes

Are sufficient details of the methods provided to allow replication by others?

Yes

Are the datasets clearly presented in a useable and accessible format?

Not applicable

Reviewer Expertise:

Childhood tuberculosis and pneumonia including in children with severe acute malnutrition.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Wellcome Open Res. 2024 Feb 1. doi: 10.21956/wellcomeopenres.22363.r71396

Reviewer response for version 1

Felix Bongomin 1

Nalwanga et al presents a well written protocol for a systematic review and meta-analysis of mortality among non-severely under nourished children with pneumonia globally following the PRISMA-P guidelines.

Minor comments

1. There is a repetitive use of "nutritional (anthropometric)" - authors could elect to use nutritional or anthropometric and apply it consistently through out the manuscript 

2. PRISMA - P not PRISMA guidelines 

3. Consider using later version of STATA , eg version 18

4. Is it the search strategy or the research question that is developed using the PICO  criteria ?  I would think it's the research question and would advise the authors to revise these sections accordingly.

5. Consider adding a sentence on meta-regression in the analysis section

6. Discusion section lasts citation of other related studies and systematic reviews , which would then be used to compare findings from this study

7. add a conclusion after the strengths and limitation section

Is the study design appropriate for the research question?

Yes

Is the rationale for, and objectives of, the study clearly described?

Yes

Are sufficient details of the methods provided to allow replication by others?

Partly

Are the datasets clearly presented in a useable and accessible format?

Yes

Reviewer Expertise:

Internal Medicine, Medical Microbiology and Research Methodology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Wellcome Open Res. 2024 Jan 27. doi: 10.21956/wellcomeopenres.22363.r72538

Reviewer response for version 1

Rouzha Pancheva 1

Comprehensiveness in Context of Current Literature: The article appears to thoroughly discuss the protocol for the topic of mortality among non-severely undernourished children with pneumonia. It references current treatment guidelines and the lack of recommendations for nutritional supplementation in non-severely malnourished children with pneumonia, indicating an awareness of the existing literature and practices. The proposed systematic review and meta-analysis aim to fill an information gap, suggesting a comprehensive approach.

Factual Accuracy and Citations: The document contains numerous references to support its statements, ranging from WHO guidelines to various studies and systematic analyses. This suggests a strong basis in factual accuracy, supported by adequate citations.

Accessible Language: The language used in the article is technical, reflecting its academic nature. However, it seems clear and precise, which is appropriate for its intended audience of clinicians and researchers. It might not be considered 'accessible' to a layperson due to the use of specialized terms and concepts, but for its target audience, it appears suitable.

Appropriateness of Conclusions: The document primarily outlines the protocol for a systematic review and meta-analysis rather than presenting conclusions from these analyses. However, the rationale for the study, its objectives, and the methodology are clearly aligned with current research literature. The anticipated outcomes suggest that the study’s conclusions will likely be relevant and appropriate in the context of existing research.

Overall, the document is well-structured and appears to meet the necessary criteria for a comprehensive, factually accurate, and appropriately targeted academic article.

Is the study design appropriate for the research question?

Yes

Is the rationale for, and objectives of, the study clearly described?

Yes

Are sufficient details of the methods provided to allow replication by others?

Yes

Are the datasets clearly presented in a useable and accessible format?

Yes

Reviewer Expertise:

Nutrition, child development, neurodevelopmental disabilities

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Maitland K: PRISMA Check List and Flow diagram for Mortality among non-severely under nourished children with pneumonia globally: protocol for a systematic review and meta-analysis.Imperial College Research Data Repository. [Dataset]. 10.14469/hpc/13333 [DOI] [PMC free article] [PubMed]

    Data Availability Statement

    Underlying data

    No data are associated with this article.

    Reporting guidelines

    The protocol has been reported according to the PRISMA-P guidelines.

    Imperial College Research Data Repository: PRISMA checklist for ‘Mortality among non-severely under nourished children with pneumonia globally: protocol for a systematic review and meta-analysis’. https://doi.org/10.14469/hpc/13333 20 .

    Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication).


    Articles from Wellcome Open Research are provided here courtesy of The Wellcome Trust

    RESOURCES